semaglutide 0.5 mg pen Wegovy® - Prefilled Losing weight and keeping it off can lessen the many health risks that come with obesity Obesema(semaglutide) 0.5mg Injection (1 Multi-dose
Description
By Manufacturing Type 16.9.7

Digital health-linked subscriptions expanded by 2.1 from 2025 to 2028

Ref: reference
These discrepancies highlight the need for further investigation

Not intended for human or veterinary use.* Retatrutide is a novel triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors

I would say GLP-1 [drugs] probably do not increase the risk of cancer
